Consensus EMEIS

Stocks

EMEIS

FR001400NLM4

Healthcare Facilities & Services

Market Closed - Euronext Paris 20:55:00 06/11/2026 +04			5-day change	1st Jan Change
10.73 ^EUR	+2.68%		+7.62%	-25.12%

11-02	Emeis: Strong quarter on occupancy but debt question pending
10-30	French and Benelux stocks-Factors to watch	RE

Evolution of the Average Target: EMEIS

Evolution of the Target Price: EMEIS

Changes in Analyst Recommendations: EMEIS

44e8a08a9352a81.DkYU7XvtQ4HCs32iE7OGF5oepQjd83jeiwGYgN_i228.RH543j6yHNSw2TjbK-TnTtN34k-7vwKb7FP3t7uovSBDNmfeOIQi7q7-RQ~e283ee727a13cd10f22fab7b7df5b78d

Analysts' recommendations: EMEIS

11-02	Emeis: Strong quarter on occupancy but debt question pending
08-03	Emeis: Operations confirmed as under control
07-31	Emeis: Strong semester: Moving the right way
04-28	Emeis holds firm with backing from TP Icap Midcap
04-09	Emeis: Pivot from firefighting to foundations
03-26	Limited 2026 energy impact; inflation remains in focus
03-04	AlphaValue/Baader Europe Lifts Emeis Rating as Operations Normalize; Estimates Revised on Preliminary FY25 Results	MT
03-03	Emeis: Opinion change, from Sell to Reduce
02-18	Emeis: Operational beat and deleveraging milestones tempered by cautious 2026 guidance
29/10/25	Emeis: Opinion change, from Sell to Reduce
29/10/25	Emeis: Good momentum expected to extend
30/09/25	Emeis: Oddo BHF raises its target price
24/09/25	Emeis: Integrating the latest strategic real-estate partnership
04/08/25	Emeis: AlphaValue still a selller
04/08/25	Emeis: Encouraging updates in asset disposals
04/06/25	Emeis: Opinion change, from Sell to Reduce
22/04/25	Emeis: Justifying disposal progress is key
13/02/25	Emeis: Opinion change, from Sell to Add
07/02/25	Emeis: FY24: on the right track
20/11/24	Emeis: Opinion change, from Buy to Add
13/11/24	Emeis: Positive Q3 lifted by a pricing and occupancy recovery; asset sales well on-track
05/10/24	Emeis: Farewell to profit warnings (?)
03/09/24	Emeis: Target cut by -32.9%
29/07/24	Emeis: Profit warning again (and again)
04/06/24	Orpea: Integrating the detailed FY23 figures

More recommendations

Residential & Long-Term Care

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	EMEIS					+51.91%
	HCA HEALTHCARE, INC.					-3.58%
	CVS HEALTH CORPORATION					+35.67%
	NATERA, INC.					+34.03%
	FRESENIUS SE & CO. KGAA					+7.48%
	LABCORP HOLDINGS INC.					+5.64%
	QUEST DIAGNOSTICS INCORPORATED					+0.64%
	TENET HEALTHCARE CORPORATION					+7.58%
	DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY					+23.1%
	IHH HEALTHCARE					+34.15%
	Average					+19.66%
	Weighted average by Cap.					+16.50%